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Structure of bone 
Bone is a dynamic structure that continuously remodels throughout its lifetime1. 
Remodeling takes place in response to changes in biomechanical forces, mechanical 
injury, or to adapt the strength of the bone2. An injury to the bone initiates a cascade of 
complex processes that regenerate the damaged areas. The process of spontaneous 
healing begins with the formation of a hematoma (blood clot), and elicits an 
inflammatory response. The hematoma attracts immune cells via signaling molecules3. 
Fibroblasts subsequently migrate towards the site of the injury and lay down extracellular 
matrix (ECM), which is primarily composed of collagenous proteins (mainly collagen 
type I) and proteoglycans4. Deposition of matrix leads to the formation of a fibrous 
cartilage (callus, rich in collagen type I), which stabilizes the healing tissue mechanically. 
As the repair progresses, the callus progressively vascularizes and mineralizes into woven 
bone, which is eventually replaced by compact bone3.  
Bone is composed—in addition to its solid hydroxyapatite structural elements—of 
four types of cells: osteoclasts, bone-lining cells (also known as osteoprogenitor cells), 
osteoblasts, and osteocytes4. Osteoclasts are multinucleated cells that are derived from 
macrophages. The primary function of osteoclasts is to digest bone by secreting acidic 
proteins and enzymes1. The bone-lining cells are of mesenchymal origin from the bone 
marrow and remain quiescent unless there is an external stimulus (mechanical, hormonal, 
and/or nutritional)2. The bone-lining cells turn into osteoblasts when the signaling 
molecules direct them to deposit bone minerals in response to an external factor 
(mechanical stimulation, microdamage, and/or injury)1. Osteoblasts are responsible for 
formation of bone by laying down collagenous matrix, which is subsequently mineralized 
by precipitation of calcium and phosphate5. During the process of mineralization, some of 
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the osteoblasts are trapped and become buried inside the matrix; there, they terminally 
differentiate into osteocytes2. The osteocytes provide a structural network for the bone. In 
this work, we studied osteoblasts, and their deposition of minerals in structured scaffolds. 
 
Scaffolds for bone 
The ideal scaffold for bone must be porous, resilient, biodegradable, biocompatible, 
osteoinductive (enabling differentiation of cells into the bone lineage), and 
osteoconductive (enabling bone to grow on a surface)6. The most common scaffolds of 
bone include polymeric materials (e.g., poly (caprolactone) (PCL), poly(lactic-co-
glycolic acid) (PLGA), poly(propylene fumarate) (PPF), polyurethane (PU), polyethylene 
glycol (PEG), gelatin, collagen, alginate, chitosan, silk, and starch), metals (e.g., stainless 
steel, platinum, titanium, and cobalt), and inorganic materials (e.g., hydroxyapatite and β-
tricalcium phosphate (β-TCP))7. Composite materials have also been used to overcome 
limitations and improve the characteristics of single-material scaffolds8. Different 
materials, which can complement the features of each other, can be combined to control 
the properties of composite scaffolds such as degradation, biocompatibility, and 
osteointegration. 
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Supporting Table S1. Limitations of the conventional orthopaedic scaffolds for encapsulation of cells. Paper can be used to address 
these limitations. 
 
Type of scaffold  Limitations 
Metals Risk of infection9, allergic reactions10, corrosion11, release of toxic metal ions into the body12, failure of osseointegration13, loss of bone 
around implant14, high cost15, multi-step fabrication procedures16. 
Polymers  Difficult to control porosity17, low mechanical strength18, lack of bioactivity19, not low-cost20, might degrade quickly21, toxic degradation 
products22, use of organic solvents23, prone to wear and tear24, poor processability25, multi-step fabrication procedures23.  
Ceramics Brittleness26, poor fracture toughness27, not resilient28, difficult to shape29, difficult to control porosity30, slow degradation rate22, failure of 
cellular ingrowth31, multi-step fabrication procedures32.  
Composite 
materials 
Difficulty in controlling/predicting degradation33, risk of toxicity from residual solvents34, non-uniform distribution of organic and inorganic 
phases35, difficulty in chemically binding the components36, difficult to shape37, not cost-effective38, multi-step fabrication procedures32. 
Hydrogels Weak mechanical integrity20, might be difficult to sterilize39, unstable functional groups40, difficulty in controlling degradation profile41, 
may be difficult to incorporate and retain bioactive functional groups42, large changes in volume due to shrinking and swelling43, multi-step 
fabrication procedures44. 
  
PAPER can be used to address the major limitations of conventional scaffolds. Paper is a widely available, low-cost, porous, flexible, and biocompatible 
material that is easy to sterilize. 
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Supporting Table S2. Disadvantages of conventional scaffolds for bone.  
 
Type of 
scaffold 
Commercially 
available 
Low-cost Easy 
fabrication  
Porosity is 
easy to control 
Flexible  Does not release 
toxic products 
Mechanically 
strong 
Biocompatible 
in vivo 
Metals  No16 No15 No16 No16 No  No12 Yes45 Yes46 
Polymers No20 No20 No23 No17 No No22 No18 Yes46 
Ceramics No32 Yes32 No32 No30 No No33 Yes29 Yes47  
Composites No32 No38 No37 No30 No No34 Yes28 No48 
Hydrogels Yes49 Yes50 No44 No51 Yes No52 No20 Yes42 
         
Paper Yes53 Yes54 Yes55 Yes56 Yes57 Yes58 Yes53, 59-62  Yes53 
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Figure S1. Biomineralized origami-inspired paper scaffolds. a) The cells were seeded in the 
paper scaffolds and cultured for 21 days. b-c) The micro-CT X-Ray scans illustrated the 
mineralized areas in the paper constructs in bright white color.  
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Figure S2. Proliferation of cells in the collagen matrix in paper scaffolds at different time points. 
We stained the nuclei of the cells to image the distribution and proliferation of the cells on days 
0, 3, 7, 14, and 21. The initial seeding density was 1.6x106 cells/sample. We stained the samples 
with DAPI (blue), and obtained the images by confocal microscopy. The results indicated that 
proliferation increased until day 3 and then decreased after day 7. Because proliferation slows 
down at the onset of mineralization, this result is expected. The scale bar represents 30 µm.  
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Figure S3. Expression of a bone-specific marker, osteocalcin, was determined by 
immunocytochemistry in the paper scaffolds. The initial cell density was 1.6x106 cells/sample. 
We carried out immunostaining for osteocalcin (red) on days 0, 3, 7, 14, and 21, and acquired the 
fluorescent images by confocal microscopy. We counter-stained the cells with DAPI (blue) to 
visualize the nuclei of the cells. The expression of osteocalcin increased until day 14 and then 
decreased. This result could be due to increasing mineralization after day 14. The scale bar 
represents 30 µm.  
 
 
